Search

Your search keyword '"Fang, X."' showing total 85 results

Search Constraints

Start Over You searched for: Author "Fang, X." Remove constraint Author: "Fang, X." Topic antineoplastic agents Remove constraint Topic: antineoplastic agents
85 results on '"Fang, X."'

Search Results

1. Hydroxychloroquine loaded hollow apoferritin nanocages for cancer drug repurposing and autophagy inhibition.

2. Chromosome instability functions as a potential therapeutic reference by enhancing chemosensitivity to BCL-XL inhibitors in colorectal carcinoma.

3. Development of VER-50589 analogs as novel Hsp90 inhibitors.

4. The RNA-binding protein LRPPRC promotes resistance to CDK4/6 inhibition in lung cancer.

5. Design, synthesis, and biological evaluation of diaryl heterocyclic derivatives targeting tubulin polymerization with potent anticancer activities.

6. Effects of exercise on chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review and meta-analysis.

7. Small Molecular Inhibitors Reverse Cancer Metastasis by Blockading Oncogenic PITPNM3.

8. CD47-blocking Antibody ZL-1201 Promotes Tumor-associated Macrophage Phagocytic Activity and Enhances the Efficacy of the Therapeutic Antibodies and Chemotherapy.

9. Combined treatment with niclosamide and camptothecin enhances anticancer effect in U87 MG human glioblastoma cells.

10. Molecular level precision and high molecular weight peptide dendrimers for drug-specific delivery.

11. Surface Decoration via Physical Interaction of Cupric Diethyldithiocarbamate Nanocrystals and Its Impact on Biodistribution and Tumor Targeting.

12. NCTD Prevents Renal Interstitial Fibrosis via Targeting Sp1/lncRNA Gm26669 Axis.

13. Enhancement of gold-nanocluster-mediated chemotherapeutic efficiency of cisplatin in lung cancer.

14. pH-Triggered Poly(ethylene glycol)-Poly(lactic acid/glycolic acid)/Croconaine Nanoparticles-Assisted Multiplexed Photoacoustic Imaging and Enhanced Photothermal Cancer Therapy.

15. Molecular and genetic biomarkers implemented from next-generation sequencing provide treatment insights in clinical practice for Waldenström macroglobulinemia.

16. Design, synthesis and antitumor activity evaluation of novel HDAC inhibitors with tetrahydrobenzothiazole as the skeleton.

17. Aminated Fullerene Abrogates Cancer Cell Migration by Directly Targeting Myosin Heavy Chain 9.

18. A proposal for a prognostic index for non-nasal type natural killer/T cell lymphoma after asparaginase-based treatment.

19. XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53.

20. Conjugated BODIPY Oligomers with Controllable Near-Infrared Absorptions as Promising Phototheranostic Agents through Excited-State Intramolecular Rotations.

21. Targeting epidermal growth factor-overexpressing triple-negative breast cancer by natural killer cells expressing a specific chimeric antigen receptor.

22. Preparation and evaluation of phytantriol liquid crystal as a liquid embolic agent.

23. MDM2 inhibitor APG-115 synergizes with PD-1 blockade through enhancing antitumor immunity in the tumor microenvironment.

24. Proteasome-Independent Protein Knockdown by Small-Molecule Inhibitor for the Undruggable Lung Adenocarcinoma.

25. A carbohydrate mimetic peptide modified size-shrinkable micelle nanocluster for anti-tumor targeting and penetrating drug delivery.

26. Trifluoperazine as an alternative strategy for the inhibition of tumor growth of colorectal cancer.

27. Molecular Engineering-Based Aptamer-Drug Conjugates with Accurate Tunability of Drug Ratios for Drug Combination Targeted Cancer Therapy.

28. Discovery and Biological evaluation of pyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione derivatives as potent Bruton's tyrosine kinase inhibitors.

29. Phenylboronic acid-functionalized polyamidoamine-mediated miR-34a delivery for the treatment of gastric cancer.

30. Diosgenin exerts its tumor suppressive function via inhibition of Cdc20 in osteosarcoma cells.

31. Immunometabolism: A new target for improving cancer immunotherapy.

32. Design, synthesis, and discovery of ocotillol-type amide derivatives as orally available modulators of P-glycoprotein-mediated multidrug resistance.

33. Signal Pathways and Therapeutic Prospects of Diffuse Large B Cell Lymphoma.

34. SBF-1 preferentially inhibits growth of highly malignant human liposarcoma cells.

35. PBA2 exhibits potent anti-tumor activity via suppression of VEGFR2 mediated-cell proliferation and angiogenesis.

36. Redox-sensitive micelles composed of disulfide-linked Pluronic-linoleic acid for enhanced anticancer efficiency of brusatol.

37. Ceritinib Enhances the Efficacy of Substrate Chemotherapeutic Agent in Human ABCB1-Overexpressing Leukemia Cells In Vitro, In Vivo and Ex-Vivo.

38. Single-step synthesis of carbon encapsulated magnetic nanoparticles in arc plasma and potential biomedical applications.

39. Bioresponsive cancer-targeted polysaccharide nanosystem to inhibit angiogenesis.

40. Anti-tumor activity of nanomicelles encapsulating CXCR4 peptide antagonist E5.

41. Identification of novel ROS inducer by merging the fragments of piperlongumine and dicoumarol.

42. AC0010, an Irreversible EGFR Inhibitor Selectively Targeting Mutated EGFR and Overcoming T790M-Induced Resistance in Animal Models and Lung Cancer Patients.

43. Synthesis, characterization and anti-cancer activity of Pluronic F68-curcumin conjugate micelles.

44. Glycyrrhetinic Acid Mediated Drug Delivery Carriers for Hepatocellular Carcinoma Therapy.

45. In Vivo Biodistribution and Anti-Tumor Efficacy Evaluation of Doxorubicin and Paclitaxel-Loaded Pluronic Micelles Decorated with c(RGDyK) Peptide.

46. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.

47. Overexpression of PI3K p110α contributes to acquired resistance to MET inhibitor, in MET-amplified SNU-5 gastric xenografts.

48. Glycyrrhetinic Acid-Mediated Polymeric Drug Delivery Targeting the Acidic Microenvironment of Hepatocellular Carcinoma.

49. Dual-functional c(RGDyK)-decorated Pluronic micelles designed for antiangiogenesis and the treatment of drug-resistant tumor.

50. Pluronic-based functional polymeric mixed micelles for co-delivery of doxorubicin and paclitaxel to multidrug resistant tumor.

Catalog

Books, media, physical & digital resources